Patients with BRAFV600-mutant glioma received vemurafenib 960 mg twice per day continuously...Twenty-four patients (median age, 32 years; 18 female and six male patients) with glioma, including...PXA (n = 7), anaplastic ganglioglioma (n = 3), pilocytic astrocytoma (n = 2),...Responses among patients with other tumor types included PR in one patient with PA who was treated for 15.3 months...One CR was observed in a patient with PXA, and five patients achieved PR...